Boundless Bio, Inc.

Analysis for Ticker: BOLD

Boundless Bio Inc is a biotechnology company that tries to find ways to stop cancer by attacking a specific part of human cells called extrachromosomal DNA. It uses a platform called Spyglass to build these drugs and a tool named ECHO to find the right patients during medical tests. Even though it has been operating since 2018 it has never earned a single cent from selling a product. The financial reality is that this company is an engine designed to burn through 259,7$ million of investor money. This math is a disaster because they have spent years taking money from regular people and giving it to landlords and executives while their medical experiments fail in the human body. It is like building a massive factory that never makes anything but costs 50,0$ million a year to keep the lights on.